PSG — PharmaSGP Holding SE Balance Sheet
0.000.00%
- €347.72m
- €384.71m
- €101.10m
- 94
- 40
- 88
- 91
Annual balance sheet for PharmaSGP Holding SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 88.5 | 8 | 20.8 | 33.9 | 40.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 11.4 | 11.1 | 7.23 | 8.3 | 9.42 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 102 | 22.4 | 32.5 | 51.5 | 62.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.254 | 0.753 | 0.541 | 1.57 | 1.18 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 104 | 24.9 | 115 | 129 | 131 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.94 | 13 | 92.7 | 22.7 | 24.6 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8.16 | 13.4 | 93.1 | 98 | 91.5 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 95.6 | 11.5 | 22.2 | 31.1 | 39.8 |
| Total Liabilities & Shareholders' Equity | 104 | 24.9 | 115 | 129 | 131 |
| Total Common Shares Outstanding |